Gilles Paintaud
Université de Tours(FR)Inserm(FR)Centre Hospitalier Universitaire de Tours(FR)
Publications by Year
Research Areas
Monoclonal and Polyclonal Antibodies Research, Chronic Lymphocytic Leukemia Research, Inflammatory Bowel Disease, Rheumatoid Arthritis Research and Therapies, Colorectal Cancer Treatments and Studies
Most-Cited Works
- → Maintenance of Remission Among Patients With Crohn's Disease on Antimetabolite Therapy After Infliximab Therapy Is Stopped(2011)589 cited
- → Withdrawal of Immunosuppression in Crohn's Disease Treated With Scheduled Infliximab Maintenance: A Randomized Trial(2008)495 cited
- → Influence of Trough Serum Levels and Immunogenicity on Long-term Outcome of Adalimumab Therapy in Crohn's Disease(2009)478 cited
- → Rituximab-Dependent Cytotoxicity by Natural Killer Cells(2004)416 cited
- → Bevacizumab in Patients With Hereditary Hemorrhagic Telangiectasia and Severe Hepatic Vascular Malformations and High Cardiac Output(2012)381 cited
- → Alterations in the Intestinal Microbiome (Dysbiosis) as a Predictor of Relapse After Infliximab Withdrawal in Crohnʼs Disease(2014)235 cited